Phosphorylation of Shiftless by casein kinase 1 δ/ε is required for its antiviral activity
Open Access
- 23 December 2025
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 99 (12) , e0186425
Abstract
Shiftless (SHFL) is a host antiviral factor that inhibits the viral −1 programmed ribosomal frameshifting (−1PRF). How the antiviral activity of SHFL is regulated is not known. Here, we report that the phosphorylation of SHFL by the casein kinase 1 delta (CK1δ) and epsilon (CK1ε) regulates its antiviral activity. The casein kinases were identified as SHFL-interacting proteins. Downregulation of the expression of the endogenous casein kinases or pharmacological inhibition of kinase activity significantly impaired the activity of SHFL to inhibit HIV-1 -1PRF and viral production. The residues T250 and T253 were identified as critical phosphorylation sites; substitution of either of the residues with alanine, resulting in the mutants SHFL-T250A or SHFL-T253A, abolished the antiviral activity of SHFL against HIV-1. The T250A mutation did not affect SHFL interaction with target RNA or the ribosomal proteins uL5 and eS31 but significantly reduced its interaction with IGF2BP proteins. Furthermore, SHFL-T250A displayed reduced association with the actively translating polysomes. These results are consistent with the notion that SHFL interaction with ribosomes is critical for its activity to inhibit −1PRF. Taken together, our results indicate that phosphorylation of SHFL by CK1δ/ε is required for its antiviral activity. IMPORTANCE: Innate immune responses and antiviral defense mechanisms are regulated through a variety of mechanisms, among which post-translational modifications, especially phosphorylation, play important roles. Deciphering the regulatory mechanisms helps understand the innate immune responses more comprehensively. SHFL is an interferon-stimulated host antiviral factor that inhibits the replication of multiple viruses. The present study revealed that phosphorylation of SHFL by casein kinase 1 δ/ε is required for its antiviral activity against HIV-1. These results provide an additional example for how immune responses are regulated. Furthermore, given that SHFL inhibits −1PRF, the present studies provide tools for further exploring the mechanisms of −1PRF.Keywords
This publication has 52 references indexed in Scilit:
- Assembly and activation of EBV latent membrane protein 1Cell, 2024
- C19orf66 Inhibits Japanese Encephalitis Virus Replication by Targeting -1 PRF and the NS3 ProteinVirologica Sinica, 2021
- Regulation of HIV-1 Gag-Pol Expression by Shiftless, an Inhibitor of Programmed -1 Ribosomal FrameshiftingCell, 2019
- Identification of new type I interferon-stimulated genes and investigation of their involvement in IFN-β activationProtein & Cell, 2018
- HIV-1 Exploits the Host Factor RuvB-like 2 to Balance Viral Protein ExpressionCell Host & Microbe, 2015
- The human phosphatase interactome: An intricate family portraitFEBS Letters, 2012
- Control of gene expression by translational recoding2012
- The casein kinase 1 family: participation in multiple cellular processes in eukaryotesCellular Signalling, 2005
- The comparative efficiencies of the Ser(P)-, Thr(P)- and Tyr(P)-residues as specificity determinants for casein kinase-1Biochemical and Biophysical Research Communications, 1992
- A synthetic β‐casein phosphopeptide and analogues as model substrates for casein kinase‐1, a ubiquitous, phosphate directed protein kinaseFEBS Letters, 1991